Dear Nebraska Biobank users,
We would like to inform you that the facility remains operational during the pandemic and continues to collect, process, and release samples. Date restrictions for accessing samples have been lifted although minor changes to the sample request process have been made due to the anticipated high demand for COVID-19 samples.
There is now a separate request form and review committee for COVID-19 related samples, please contact Yuning Zhang with questions. The EHR Data Access core is working with our campus informatics, infectious disease, and clinical laboratory professionals to refine how those samples can best be identified in the medical record.
The Nebraska Biobank is a Nebraska Research Initiative (NRI) developed joint effort of the University of Nebraska Medical Center (UNMC) and Nebraska Medicine to facilitate research in health care. The Nebraska Biobank is made up of residual blood samples from patients who want to take part.
Patients at the Nebraska Medicine clinics and hospitals are asked at check-in to participate by donating any blood left from their scheduled laboratory tests to the Nebraska Biobank. Serum, Plasma, and DNA are recovered from the consented samples and stored for future research studies. Deidentified data from the Electronic Health Record (EHR) such as age range, diagnosis, and medications are linked to the stored samples. Any faculty member from the University of Nebraska system may request samples from the biobank for their research projects but all requests are subject to feasibility and scientific merit review.
The Nebraska Biobank also offers sample management services to investigators for clinical trials and registries.